Needle-free Injectors Market Predicted To Reach USD 2.4 Billion By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEilVkV4XbvsSFV7n16Qq-gpYlq6N-soKXn51xasv-J3A0prYgqw6JO5IOUaLmy-_-YOzip-sm5R3zycK8-FDoPWLFJzfdv0VvvUru78r0iaqXGX3nsRLKo6NssvB47AMM17VEmopnxqutmKQZU2a9nCw1RJwHQArLEgLPK7aZFVYxXIJP_nyrp93VliDg/s320/Needle-free%20Injectors%20Market.png)
San Francisco, 31 Jan 2023: The Report Needle-free Injectors Market Size, Share & Trends Analysis Report By Product (Fillable, Prefilled), By Technology, By Type (Liquid-based Needle-free Injectors), By Usability, By Application (Vaccine Delivery), By Region, And Segment Forecasts, 2023 - 2030 The global needle-free injectors market size is expected to reach USD 2.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.8% from 2022 to 2030. Increasing prevalence of chronic diseases and rising patient volume are factors projected to enhance the demand for needle-free injectors. As a result of a sedentary lifestyle, the prevalence of lifestyle-associated diseases such as diabetes and hypertension is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters such as blood pressure and blood sugar levels. This allows integration of healthcar